NCT03407768View on ClinicalTrials.gov

Role of Individualized Intervention(s) in Hormone-Receptor Positive Early-stage Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

November 30, 2024

Study Completion Date

November 30, 2024

Conditions
Breast CancerPremenopausal Breast CancerHormone Receptor Positive Tumor
Interventions
BEHAVIORAL

Individualized interventions

"A participant will be able to select one or more (or no intervention) based on her preferences.~Individualized exercise program Yoga and mindfulness Massage therapy Acupuncture Others: Women who are not interested in any above intervention but like to explore other interventions will be offered material pertinent to their choice of complimentary techniques."

Trial Locations (2)

Unknown

Allan Blair Cancer Center, Regina

S7N4H4

Saskatoon Cancer Center, Saskatoon

All Listed Sponsors
lead

University of Saskatchewan

OTHER

NCT03407768 - Role of Individualized Intervention(s) in Hormone-Receptor Positive Early-stage Breast Cancer | Biotech Hunter | Biotech Hunter